IT1277914B1 - Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e - Google Patents

Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e

Info

Publication number
IT1277914B1
IT1277914B1 IT95RM000573A ITRM950573A IT1277914B1 IT 1277914 B1 IT1277914 B1 IT 1277914B1 IT 95RM000573 A IT95RM000573 A IT 95RM000573A IT RM950573 A ITRM950573 A IT RM950573A IT 1277914 B1 IT1277914 B1 IT 1277914B1
Authority
IT
Italy
Prior art keywords
protease
hcv
polypeptides
proteolytic activity
procedure
Prior art date
Application number
IT95RM000573A
Other languages
English (en)
Inventor
Christian Steinkuhler
Antonello Pessi
Elisabetta Bianchi
Marina Taliani
Licia Tomei
Andrea Urbani
Francesco Raffaele De
Frank Narjes
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11403536&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1277914(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Priority to IT95RM000573A priority Critical patent/IT1277914B1/it
Publication of ITRM950573A0 publication Critical patent/ITRM950573A0/it
Priority to PCT/IT1996/000163 priority patent/WO1997008304A2/en
Priority to AT96926574T priority patent/ATE290070T1/de
Priority to ES96926574T priority patent/ES2236743T3/es
Priority to BR9610039A priority patent/BR9610039A/pt
Priority to CN96196406A priority patent/CN1193997A/zh
Priority to DE69634406T priority patent/DE69634406T2/de
Priority to AU66686/96A priority patent/AU716379B2/en
Priority to PT96926574T priority patent/PT846164E/pt
Priority to DK96926574T priority patent/DK0846164T3/da
Priority to CA002228265A priority patent/CA2228265C/en
Priority to JP51008297A priority patent/JP3310298B2/ja
Priority to EP96926574A priority patent/EP0846164B1/en
Publication of ITRM950573A1 publication Critical patent/ITRM950573A1/it
Publication of IT1277914B1 publication Critical patent/IT1277914B1/it
Application granted granted Critical
Priority to US09/011,961 priority patent/US6197536B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT95RM000573A 1995-08-22 1995-08-22 Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e IT1277914B1 (it)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IT95RM000573A IT1277914B1 (it) 1995-08-22 1995-08-22 Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e
EP96926574A EP0846164B1 (en) 1995-08-22 1996-08-20 Method for assaying in vitro the proteolytic activity of polypeptides having hcv ns3 protease activity and peptide substrates to be used in this method.
AU66686/96A AU716379B2 (en) 1995-08-22 1996-08-20 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the HCV NS3 protease
PT96926574T PT846164E (pt) 1995-08-22 1996-08-20 Metodologia para produzir, purificar e analisar polipeptidos com a actividade proteolitica da protease hcv ns3
ES96926574T ES2236743T3 (es) 1995-08-22 1996-08-20 Procedimiento de ensayo in vitro de la actividad proteolitica de polipeptidos con actividad de proteasa hcv ns3 y peptidos sustratos a usar en dicho procedimiento.
BR9610039A BR9610039A (pt) 1995-08-22 1996-08-20 Polipeptídeos isolados vetores de expressão célula hospedeira processos para preparar um dos polipeptídeos e reproduzir e efetivamente ensaiar in vitro a atividade proteolitica da proteína NS3 do HCV peptídeos e depsipeptídeos
CN96196406A CN1193997A (zh) 1995-08-22 1996-08-20 产生和纯化并测定具有hcvns3蛋白酶蛋白水解活性的多肽的方法
DE69634406T DE69634406T2 (de) 1995-08-22 1996-08-20 Verfahren zum In-Vitro-Texten der proteolytischen Aktivität von Polypeptiden mit HCV NS3 Protease-Aktivität sowie Peptidsubstrate, die in diesem Verfahren verwendet werden
PCT/IT1996/000163 WO1997008304A2 (en) 1995-08-22 1996-08-20 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease
AT96926574T ATE290070T1 (de) 1995-08-22 1996-08-20 Verfahren zum in vitro testen der proteolytischen aktivität von polypeptiden mit hcv ns3 protease aktivität sowie peptidsubstrate, die in diesem verfahren verwendet werden
DK96926574T DK0846164T3 (da) 1995-08-22 1996-08-20 Metodologi til fremstilling, oprensning og assay af polypeptider med den proteolytiske aktivitet af HCV NS3-protease
CA002228265A CA2228265C (en) 1995-08-22 1996-08-20 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease
JP51008297A JP3310298B2 (ja) 1995-08-22 1996-08-20 Ｈｃｖ ｎｓ３プロテアーゼのタンパク質分解活性を有するポリぺプチドを製造し、精製し、分析する方法
US09/011,961 US6197536B1 (en) 1995-08-22 1998-02-23 Methodology to produce, and purify and assay polypeptides with the proteolytic activity of the HCV NS3 protease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95RM000573A IT1277914B1 (it) 1995-08-22 1995-08-22 Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e

Publications (3)

Publication Number Publication Date
ITRM950573A0 ITRM950573A0 (it) 1995-08-22
ITRM950573A1 ITRM950573A1 (it) 1997-02-22
IT1277914B1 true IT1277914B1 (it) 1997-11-12

Family

ID=11403536

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95RM000573A IT1277914B1 (it) 1995-08-22 1995-08-22 Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e

Country Status (14)

Country Link
US (1) US6197536B1 (it)
EP (1) EP0846164B1 (it)
JP (1) JP3310298B2 (it)
CN (1) CN1193997A (it)
AT (1) ATE290070T1 (it)
AU (1) AU716379B2 (it)
BR (1) BR9610039A (it)
CA (1) CA2228265C (it)
DE (1) DE69634406T2 (it)
DK (1) DK0846164T3 (it)
ES (1) ES2236743T3 (it)
IT (1) IT1277914B1 (it)
PT (1) PT846164E (it)
WO (1) WO1997008304A2 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1285158B1 (it) * 1996-09-17 1998-06-03 Angeletti P Ist Richerche Bio Polipeptidi solubili con l'attivita' di serino-proteasi di ns3 del virus dell'epatite c, e procedimento per la loro preparazione e il
GB9623908D0 (en) * 1996-11-18 1997-01-08 Hoffmann La Roche Amino acid derivatives
GB9707659D0 (en) * 1997-04-16 1997-06-04 Peptide Therapeutics Ltd Hepatitis C NS3 Protease inhibitors
ES2143918B1 (es) * 1997-05-23 2001-01-01 Inst Cientifico Tecnol Navarra Peptidos inhibidores de la proteasa c y su utilizacion en la preparacion de composiciones utiles en las infecciones causadas por el virus de la hepatitis c.
WO1999028482A2 (en) * 1997-11-28 1999-06-10 Schering Corporation Single-chain recombinant complexes of hepatitis c virus ns3 protease and ns4a cofactor peptide
IT1299134B1 (it) * 1998-02-02 2000-02-29 Angeletti P Ist Richerche Bio Procedimento per la produzione di peptidi con proprieta' inibitrici della proteasi ns3 del virus hcv, peptidi cosi' ottenibili e peptidi
WO2000001718A2 (en) * 1998-07-02 2000-01-13 University Of Florida Ns4a-ns3 catalytic domain of hepatitis c
US6323180B1 (en) * 1998-08-10 2001-11-27 Boehringer Ingelheim (Canada) Ltd Hepatitis C inhibitor tri-peptides
IL143798A0 (en) 1999-01-08 2002-04-21 Bristol Myers Squibb Co Hepatitis c virus ns3 protease
WO2000066623A2 (en) * 1999-05-04 2000-11-09 Boehringer Ingelheim (Canada) Ltd. Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease
CA2383411A1 (en) * 1999-08-30 2001-03-08 Paul L. Darke Hepatitis c virus replication inhibitors
GB0006537D0 (en) * 2000-03-17 2000-05-10 Angeletti P Ist Richerche Bio Assays and screening methods
MXPA03004835A (es) 2000-12-15 2005-04-19 Boehringer Ingelheim Ltd Proteasa ns2/3 activa, purificada de virus de hepatitis c.
MXPA05004276A (es) * 2002-10-29 2005-08-03 Boehringer Ingelheim Int Ns3 de proteasa de hcv resistente a inhibidor.
US7834145B2 (en) 2005-03-22 2010-11-16 Merck Sharp & Dohme Corp. HCV protease substrates
EP1945797B1 (en) * 2005-10-28 2012-05-30 Boehringer Ingelheim International GmbH Hepatitis c virus ns2/3 activity assay
CN103012565B (zh) * 2013-01-15 2014-07-16 成都天台山制药有限公司 一种曲普瑞林及其固相合成制备方法
JP6564539B1 (ja) 2018-09-14 2019-08-21 長瀬産業株式会社 スルホン酸化合物によるペプチド精製方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133402T2 (de) * 1990-04-04 2004-11-11 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Protease von hepatitis-c-virus
WO1995011918A1 (fr) * 1993-10-29 1995-05-04 Srl, Inc. Compose peptidique antigenique et methode de dosage immunologique
JPH08205893A (ja) * 1994-12-08 1996-08-13 Sumitomo Metal Ind Ltd Ｈｃｖプロテアーゼ活性測定法
US5767233A (en) * 1995-05-12 1998-06-16 Schering Corporation Soluble cleavable substrates of the hepatitis C virus protease

Also Published As

Publication number Publication date
PT846164E (pt) 2005-07-29
ITRM950573A0 (it) 1995-08-22
WO1997008304A2 (en) 1997-03-06
DE69634406D1 (de) 2005-04-07
CA2228265C (en) 2002-08-13
EP0846164A2 (en) 1998-06-10
CA2228265A1 (en) 1997-03-06
JP3310298B2 (ja) 2002-08-05
US6197536B1 (en) 2001-03-06
AU716379B2 (en) 2000-02-24
DE69634406T2 (de) 2006-04-13
ATE290070T1 (de) 2005-03-15
EP0846164B1 (en) 2005-03-02
CN1193997A (zh) 1998-09-23
ITRM950573A1 (it) 1997-02-22
AU6668696A (en) 1997-03-19
BR9610039A (pt) 1999-07-06
ES2236743T3 (es) 2005-07-16
DK0846164T3 (da) 2005-06-27
JPH10511556A (ja) 1998-11-10
WO1997008304A3 (en) 1997-05-22

Similar Documents

Publication Publication Date Title
IT1277914B1 (it) Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e
Mizuno et al. A novel protease from yeast with specificity towards paired basic residues
Nishimura et al. Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro
Hite et al. cDNA sequences for four snake venom metalloproteinases: structure, classification, and their relationship to mammalian reproductive proteins
CA2182521A1 (en) Method for Reproducing in Vitro the Proteolytic Activity of the NS3 Protease of Hepatitis C Virus (HCV)
CA2170491C (en) Subtilisin bpn' variants with decreased adsorption and increased hydrolysis
Stoecker et al. Fluorescent oligopeptide substrates for kinetic characterization of the specificity of Astacus protease
Siigur et al. cDNA Cloning and Deduced Amino Acid Sequence of Fibrinolytic Enzyme (Lebetase) fromVipera lebetinaSnake Venom
CA2189428A1 (en) Fabric cleaning compositions containing subtilisin bpn' variants
JPH09510363A (ja) 非タンパク質プロテアーゼ抑制剤を使用するプロテアーゼ酵素の製造
IL148152A0 (en) Sequence-specific dna recombination in eukaryotic cells
Harris A collagenolytic system produced by primary cultures of rheumatoid nodule tissue
WO1990003435A3 (fr) Acide nucleique codant pour l'enzyme de conversion de l'angiotensine (eca) humaine, et ses applications, notamment pour le diagnostic in vitro de l'hypertension arterielle
Kay et al. Substrate specificity and inhibitors of aspartic proteinases
Ortiz et al. Diastereotopic covalent binding of the natural inhibitor leupeptin to trypsin: detection of two interconverting hemiacetals by solution and solid-state NMR spectroscopy
WO1994026925A3 (en) Processes for producing an enzyme
Stroud et al. Structure-function relationships in the serine proteases
NZ500844A (en) Nucleotide sequences (mutated GDF-9B polypeptides) involved in increasing and decreasing mammalian ovulation rate
HUP0104996A2 (hu) Enzimes oxidatív dezaminálási eljárás
O'CONNELL et al. A 13C-NMR study of the role of Asn-155 in stabilizing the oxyanion of a subtilisin tetrahedral adduct
Tsushima et al. Cleavage of human big endothelin-1 by Candida albicans aspartic proteinase
WO2000026348A3 (en) Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
James Relationship between the structures and activities of some microbial serine proteases. II. Comparison of the tertiary structures of microbial and pancreatic serine proteases
CA2271697C (en) Tissue type plasminogen activator (t-pa) variants: compositions and methods of use
Hawkins et al. Differences in the secondary structures of native and denatured yeast leucine transfer ribonucleic acid

Legal Events

Date Code Title Description
0001 Granted